Literature DB >> 18431237

Dearterialization of the liver causes intrahepatic cholestasis due to reduced bile transporter expression.

Harm Hoekstra1, Yinghua Tian, Wolfram Jochum, Bruno Stieger, Rolf Graf, Robert J Porte, Pierre-Alain Clavien.   

Abstract

BACKGROUND: Bile duct injury after hepatic artery thrombosis (HAT) in liver transplantation is believed to be caused by ischemia predominantly. We aimed to define the involvement of bile secretory dysfunction in the pathogenesis of liver injury after HAT.
METHODS: In a murine model, the main hepatic artery, the extrahepatic peribiliary plexus, or both arterial connections to the liver were interrupted (n=5 for each group). After 1, 14, or 28 days, hepatobiliary function was assessed by analysis of bile transporter expression, serum bile acids and bilirubin, and hepatic ATP content. In addition, cellular injury was assessed by light microscopy and biochemical markers.
RESULTS: There were no signs of hepatobiliary dysfunction or injury in sham-operated animals or in mice with interruption of the hepatic artery or the extrahepatic peribiliary plexus alone. However, as early as 24 hr after complete dearterialization, bile transporter expression was significantly reduced and intrahepatic cholestasis started to progress the following weeks. Histologic studies at 28 days after complete dearterialization showed severe hepatobiliary injury.
CONCLUSIONS: This study indicates that arterial blood supply is critical for normal bile secretion. Bile duct injury after complete arterial deprivation is preceded by a loss of bile secretory function and subsequent intrahepatic cholestasis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18431237     DOI: 10.1097/TP.0b013e31816b2465

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  7 in total

1.  Intermittent ischaemia maintains function after ischaemia reperfusion in steatotic livers.

Authors:  Mathilde Steenks; Mark C P M van Baal; Vincent B Nieuwenhuijs; Menno T de Bruijn; Marc Schiesser; Mike H Teo; Tom Callahan; Rob T A Padbury; Greg J Barritt
Journal:  HPB (Oxford)       Date:  2010-05       Impact factor: 3.647

Review 2.  Secondary Sclerosing Cholangitis in Critically Ill Patients: An Underdiagnosed Entity.

Authors:  Pedro Martins; Mariana Verdelho Machado
Journal:  GE Port J Gastroenterol       Date:  2019-07-30

3.  Partial Portal Vein Arterialization Attenuates Acute Bile Duct Injury Induced by Hepatic Dearterialization in a Rat Model.

Authors:  Jun Jiang; Jishu Wei; Junli Wu; Wentao Gao; Qiang Li; Kuirong Jiang; Yi Miao
Journal:  Biomed Res Int       Date:  2016-10-30       Impact factor: 3.411

4.  Alteration of MRP2 expression and the graft outcome after liver transplantation.

Authors:  Nam-Joon Yi; Joohyun Kim; YoungRok Choi; Heyoung Kim; Kyoung Bun Lee; Ja-June Jang; Jae Young Lee; Jeong Min Lee; Joon Koo Han; Kwang-Woong Lee; Kyung-Suk Suh
Journal:  Ann Surg Treat Res       Date:  2018-10-25       Impact factor: 1.859

5.  Secondary sclerosing cholangitis in critically ill patients: a rare disease precipitated by severe SARS-CoV-2 infection.

Authors:  Kate Edwards; Miles Allison; Sekina Ghuman
Journal:  BMJ Case Rep       Date:  2020-11-09

6.  Human menstrual blood-derived stem cell transplantation suppresses liver injury in DDC-induced chronic cholestasis.

Authors:  Ya Yang; Yanfei Chen; Yalei Zhao; Feiyang Ji; Lingjian Zhang; Shima Tang; Sainan Zhang; Qingqing Hu; Zuhong Li; Fen Zhang; Qian Li; Lanjuan Li
Journal:  Stem Cell Res Ther       Date:  2022-02-05       Impact factor: 6.832

7.  Experimental obstructive cholestasis: the wound-like inflammatory liver response.

Authors:  María-Angeles Aller; Jorge-Luis Arias; Jose García-Domínguez; Jose-Ignacio Arias; Manuel Durán; Jaime Arias
Journal:  Fibrogenesis Tissue Repair       Date:  2008-11-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.